Loading...
Back to narrative

Update shared on 01 Nov 2025

Fair value Increased 8.84%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
2.7%
7D
-16.7%

Materion's analyst price target has increased from $132 to approximately $143.67, with analysts citing stronger revenue growth forecasts but also noting uncertainties in demand and procurement risks which temper optimism.

Analyst Commentary

Industry analysts have provided a range of perspectives on Materion's recent performance and future outlook. While there is recognition of the company’s achievements and potential, commentary also notes ongoing headwinds that could affect continued momentum.

Bullish Takeaways

  • Bullish analysts point to successful business wins in key growth markets as a positive indicator for revenue expansion.
  • There is confidence in the company’s ability to tap into new opportunities while maintaining cost discipline, supporting the recent increase in price targets.
  • Positive coverage initiations with Buy ratings reflect optimism about long-term growth and the company’s positioning in strategic markets.
  • The upward trend in Materion’s share price underscores favorable market sentiment and supports a more optimistic valuation scenario.

Bearish Takeaways

  • Bearish analysts remain cautious about the uncertainty of demand, particularly with respect to 2026 clad material identification, which introduces risk to sustained growth.
  • Procurement risks, especially those related to the company's Chinese customer base, continue to be highlighted as factors that could negatively impact execution and profitability.
  • Some recent downgrades reflect a view that, despite progress, the balance of risks and rewards is less favorable at current valuation levels after a significant share price rise.
  • Lingering concerns around the pace and consistency of material adoption in new projects temper some of the near-term optimism in analyst forecasts.

What's in the News

  • Materion Corporation has announced a share repurchase program and approved up to $50 million in stock buybacks. (Key Developments)
  • The Board of Directors authorized the share buyback plan on October 29, 2025. (Key Developments)
  • Materion has entered into an agreement with Commonwealth Fusion Systems to supply beryllium fluoride for use in fusion power plants, supporting the development of CFS' ARC power facility in Virginia. Shipments from Materion's Elmore, OH, facility will begin this year. (Key Developments)

Valuation Changes

  • Consensus Analyst Price Target: Increased from $132 to approximately $143.67, reflecting a more optimistic valuation outlook.
  • Discount Rate: Increased slightly from 7.90 percent to 8.03 percent, which suggests higher perceived risk or cost of capital in current forecasts.
  • Revenue Growth: The projected annual revenue growth rate has increased from 7.24 percent to 8.94 percent.
  • Net Profit Margin: Decreased significantly from 16.30 percent to 9.77 percent, indicating expectations of thinner profitability despite revenue gains.
  • Future P/E: Increased from 9.56x to 16.53x, pointing to higher anticipated earnings multiples in future periods.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.